CAIRO: Locally-produced hepatitis C treatment, Sovaldi, will be available Saturday at a cost of 900 EGP ($114) instead of 1,200 EGP at pharmacies across Egypt, a member of the National Committee for Control of Viral Hepatitis (NCCVH,) Yehia Shazly, told Youm7 Thursday.
NCCVH previously announced that around 157,000 patients have been treated using the Egyptian-made Sovaldi during 2015, after the country started a strategy of manufacturing drugs at subsidized prices instead of importing them.
Having one of the highest infection rates of hepatitis C infection in the world, Egypt started in 2014 a treatment regimen based on imported medications that have proved a breakthrough in treating the virus.
Some 17,000 remaining bottles of the imported Sovaldi will be pumped into liver treatment centers starting from Saturday, Shazly added.
Shazly noted that by the end of January, a total of 150,000 bottles of the locally-made medicine, Daklinza, will be available at liver centers, with 25,000 will be distributed Saturday.
Per the Health Ministry’s decision, importing medications was halted two months ago, according to Shazly, adding that the treatment will be basically dependent on the locally-made drugs.
The ministry hopes to cure a total of 500,000 Hepatitis C patients across Egypt in 2016, using the Egypt-made regimen, Deputy Head of NCCVH Waheed Dous previously told Youm7.
Additional reporting by Waleed Abdel Salam